Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Evidence With Checkpoint Inhibition in HCC

February 15th 2017

Emerging Multikinase Inhibitors in HCC

February 15th 2017

Emerging c-MET Inhibitors in HCC

February 15th 2017

Current Understanding With Biomarkers in HCC

February 15th 2017

Underlying Cirrhosis in the Second-Line Setting of HCC

February 15th 2017

Incorporating Regorafenib in the HCC Treatment Landscape

February 15th 2017

Improving Survival in HCC

February 15th 2017

Dosing Strategies With Sorafenib in HCC

February 15th 2017

HCC: Timing of Locoregional and Systemic Therapies

February 15th 2017

Locoregional Therapy Options in HCC

February 15th 2017

Radiofrequency Ablation and Curative Intent in HCC

February 15th 2017

Resection vs Transplant in HCC: Factors to Consider

February 15th 2017

Liver Transplant Candidacy in HCC

February 15th 2017

Multidisciplinary Approaches in HCC

February 15th 2017

Dr. Terashima on Future of Bursectomy and Omentectomy for Gastric Cancer

February 15th 2017

Masanori Terashima, MD, PhD, FACS, Shizuoka Cancer Center, chairman of the Japanese Clinical Oncology Group, discusses the future of bursectomy and omentectomy for patients with gastric cancer.

Induction Regimen Achieves 80% DCR in Advanced Pancreatic Cancer

February 14th 2017

The combination of nanoparticle albumin-bound-paclitaxel and gemcitabine led to no new or unexpected adverse events in a small study of patients with locally advanced pancreatic cancer.

Strosberg Discusses Latest Lutathera Data in Midgut Neuroendocrine Tumors

February 14th 2017

Jonathan Strosberg, MD, discusses the latest results from the NETTER-1 trial in midgut neuroendocrine tumors.

Ongoing Clinical Trials in Colorectal Cancer

February 10th 2017

Broad Molecular Profiling in Colorectal Cancer

February 10th 2017

Survivorship Care Plans in Colorectal Cancer

February 10th 2017